FEDERAL COURT OF AUSTRALIA
Cytec Industries Inc. v Nalco Company [2021] FCA 970
Appeal from: Cytec Industries Inc. v Nalco Company [2019] APO 2 File numbers: NSD 130 of 2019 Judgment of: BURLEY J Date of judgment: 19 August 2021 Catchwords: PATENTS – appeal from decision of delegate of the Commissioner of Patents – patent application for method of reducing aluminosilicate scale – claims of patent application amended following delegate’s decision – hearing de novo
PATENTS – claim construction – whether claims include within their scope a reaction product mixture containing a single type of small molecule
PATENTS – validity – lack of support – comparison between invention specified in the claims and that described in the specification – technical contribution to the art – lack of support established
PATENTS – validity – lack of clear and complete description – classical sufficiency – whether specification enables skilled addressee to perform invention over the whole area claimed without undue burden – lack of clear and complete description established
PATENTS – validity – best method – characterisation of invention – where certain details in examples not disclosed – no failure to disclose best method
PATENTS – validity – lack of novelty – whether patent application anticipated by earlier filed specification – whether grace period provisions apply to “whole of contents” documents – grace period applies – lack of novelty not establishedLegislation: Intellectual Property Laws Amendment (Raising the Bar) Act 2012 (Cth) ss 3 and Sch 6
Intellectual Property Laws Amendment (Raising the Bar) Bill 2011 (Cth)
Patents Act 1952 (Cth)
Patents Act 1990 (Cth) ss 18, 24, 40(2)(a), 40(2)(aa), 40(3), 59, 60, 65, 67, 79B, 105 and Sch 1
Convention on the Grant of European Patents, opened for signature 5 October 1973, 1065 UNTS 199 (entered into force 7 October 1977) art 83
Intellectual Property Legislation Amendment (Raising the Bar) Regulation 2013 (No 1) (Cth) reg 4 and sch 6
Patents Act 1977 (UK) s 14(3)
Patents Regulations 1991 (Cth) regs 2.2(1A), 2.3(1A), 3.13D, 6.3 and 23.26(4)
Cases cited: Commonwealth Scientific and Industrial Research Organisation v BASF Plant Science GmbH [2020] FCA 328; 151 IPR 181
CSR Building Products Ltd v United States Gypsum Company [2015] APO 72
Evolva SA [2017] APO 57
GlaxoSmithKline Consumer Healthcare Investments (Ireland) (No 2) Limited v Generic Partners Pty Limited [2018] FCAFC 71; 264 FCR 474
Jupiters Ltd v Neurizon Pty Ltd [2005] FCAFC 90; 222 ALR 155
Kimberly-Clark Australia Pty Ltd v Arico Trading International Pty Ltd [2001] HCA 8; 207 CLR 1
Les Laboratoires Servier v Apotex Pty Ltd [2016] FCAFC 27; 247 FCR 61
Merck Sharp & Dohme Corporation v Wyeth LLC (No 3) [2020] FCA 1477; 155 IPR 1
Mont Adventure Equipment Pty Ltd v Phoenix Leisure Group Pty Ltd [2009] FCAFC 84; 176 FCR 575
Novartis AG v Johns & Johnson Medical Ltd [2010] EWCA Civ 1039; [2011] E.C.C. 10
Pfizer Overseas Pharmaceuticals & Ors v Eli Lilly & Co [2005] FCAFC…
Keep reading for free
Create a free CaseChat account to read Cytec Industries Inc. v Nalco Company and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2021] FCA 970
- Decision Date
CaseChat Overview and Summary
The court had to determine several legal issues, including whether the claims of the patent application included a reaction product mixture containing a single type of small molecule, whether the invention was sufficiently supported and described in the specification, and whether the patent application anticipated an earlier filed specification. The court also had to consider whether the patent application disclosed the best method of performing the invention and whether the invention was novel over the prior art.
In its reasoning, the court found that the claims of the patent application did not include a reaction product mixture containing a single type of small molecule. The court also found that the invention was not sufficiently supported and described in the specification, and that the specification did not enable a skilled addressee to perform the invention over the whole area claimed without undue burden. The court further found that the patent application did not anticipate an earlier filed specification, as the grace period provisions applied to the earlier specification. However, the court did not find that the patent application failed to disclose the best method of performing the invention.
The court's final orders were that the parties confer and supply to the chambers of Justice Burley, within 28 days, short minutes of orders giving effect to these reasons. If the parties were unable to agree to the terms of the short minutes, the areas of disagreement should be set out in mark-up. The proceedings were listed for case management at 9.30am on 13 October 2021.
Orders
Orders of the court
1. The parties confer and supply to the chambers of Justice Burley, within 28 days, short minutes of orders giving effect to these reasons.
2. Insofar as the parties are unable to agree to the terms of the short minutes referred to in order 1, including the appropriate order as to costs, the areas of disagreement should be set out in mark-up.
3. The proceedings be listed for case management at 9.30am on 13 October 2021.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.